Gene · 1317
Papers1,953
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,953
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis, a potential target for the therapy of diabetic critical limb ischemia. | Free Radic Biol Med | 2025 | 40246253 | PubTator, text mining | PubMed |
| Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. | Cancer Cell | 2025 | 40215978 | PubTator, text mining | PubMed |
| Induction of Cuproptosis by Dichloromethane Extract From Patrinia scabiosaefolia Fisch on K562 Cells. | Environ Toxicol | 2025 | 40177825 | PubTator, text mining | PubMed |
| Common Regulatory Mechanisms Mediated by Cuproptosis Genes in Inflammatory Bowel Disease and Major Depressive Disorder. | Genes (Basel) | 2025 | 40149491 | PubTator, text mining | PubMed |
| PER2 interaction with HSP70 promotes cuproptosis in oral squamous carcinoma cells by decreasing AKT stability. | Cell Death Dis | 2025 | 40113747 | PubTator, text mining | PubMed |
| Cadmium and Copper Stress Responses in Soapbark Tree (Quillaja saponaria): Effects on Growth, Metal Accumulation, Saponin Concentration, and Gene Expression. | Plants (Basel) | 2025 | 40094634 | PubTator, text mining | PubMed |
| METTL3 suppressing SLC31A1 m6A modification regulates trophoblast migration and invasion. | Placenta | 2025 | 40088504 | PubTator, text mining | PubMed |
| Fucoxanthin suppresses pancreatic cancer progression by inducing bioenergetics metabolism crisis and promoting SLC31A1‑mediated sensitivity to DDP. | Int J Oncol | 2025 | 40052552 | PubTator, text mining | PubMed |
| SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis. | Eur Heart J | 2025 | 40048660 | PubTator, text mining | PubMed |
| The up-regulation of PTBP1 expression level in patients with Insomnia by senile dementia and promote cuproptosis of nerve cell by SLC31A1. | Sleep Med | 2025 | 39985973 | PubTator, text mining | PubMed |
| Endothelial Cu Uptake Transporter CTR1 Senses Disturbed Flow to Promote Atherosclerosis through Cuproptosis. | bioRxiv | 2025 | 39975331 | PubTator, text mining | PubMed |
| SRF/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC. | Int Immunopharmacol | 2025 | 39930648 | PubTator, text mining | PubMed |
| SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer. | Neoplasia | 2025 | 39904115 | PubTator, text mining | PubMed |
| Exploring the Gating Mechanism of the Human Copper Transporter, hCtr1, Using EPR Spectroscopy. | Biomolecules | 2025 | 39858521 | PubTator, text mining | PubMed |
| Exploring the impact of cuproptosis-related genes on immune infiltration in rheumatoid arthritis. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39800811 | PubTator, text mining | PubMed |
| Taxifolin regulates SLC31A1-mediated cuproptosis and tumor progression in hepatocellular carcinoma. | Hum Cell | 2025 | 39752031 | PubTator, text mining | PubMed |
| A Copper-Binding Peptide with Therapeutic Potential against Alzheimer's Disease: From the Blood-Brain Barrier to Metal Competition. | ACS Chem Neurosci | 2025 | 39723808 | PubTator, text mining | PubMed |
| Copper homeostasis and neurodegenerative diseases. | Neural Regen Res | 2025 | 39589160 | PubTator, text mining | PubMed |
| Copper Dysmetabolism is Connected to Epithelial-Mesenchymal Transition: A Pilot Study in Colorectal Cancer Patients. | Biol Trace Elem Res | 2025 | 39557817 | PubTator, text mining | PubMed |
| The Effect of Cuproptosis-Related Proteins on Macrophage Polarization in Mesothelioma is Revealed by scRNA-seq. | Biol Trace Elem Res | 2025 | 39177724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1317/papers?page=7